You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Nuvo Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NUVO PHARM, and what generic alternatives to NUVO PHARM drugs are available?

NUVO PHARM has seventeen approved drugs.

There are four US patents protecting NUVO PHARM drugs.

Summary for Nuvo Pharm

US Patents:	4
Tradenames:	14
Ingredients:	14
NDAs:	17

Drugs and US Patents for Nuvo Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nuvo Pharm	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	205019-002	Dec 5, 2014	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
Nuvo Pharms Inc	FOLIC ACID	folic acid	TABLET;ORAL	204418-001	Jul 28, 2015	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
Nuvo Pharms Inc	SULFASALAZINE	sulfasalazine	TABLET, DELAYED RELEASE;ORAL	075339-001	Jan 11, 2002	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Nuvo Pharm	DEXTROAMPHETAMINE SULFATE	dextroamphetamine sulfate	TABLET;ORAL	210059-001	Oct 18, 2017	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
Nuvo Pharm	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	TABLET;ORAL	207119-005	Apr 12, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Nuvo Pharm	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	209799-004	Dec 28, 2017	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Nuvo Pharm	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	209799-002	Dec 28, 2017	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for NUVO PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	2.0%	➤ Subscribe	2014-06-03
➤ Subscribe	Topical Solution	1.5%	➤ Subscribe	2012-07-11

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.